Indication
PLERIXA is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with NHL and MM.
Note
Precaution
- Plerixa is a prescription drug and should be used under proper medical guidance and advice.
- To be sold by retail on the prescription of Oncologist only.
- This injection should not be used if it contains visible particulate matter. Do not use if cloudiness or precipitate is observed
- Plerixa may cause fetal harm when administered to a pregnant woman.
